Description:FIELD OF THE INVENTION
This invention relates to Drip Monitoring System for Cancer Patients During Chemotherapy. BACKGROUND OF THE INVENTION
The invention is an automated drip monitoring system for cancer patients during chemotherapy treatment which can be used by oncology specialists for the management of drip flow within the time. It assures the accurate amount of chemotherapy drug to drip inside the cancer patient’s body with a steady rate of flow. In case of chemotherapy injection, some of the drugs are administered to the site of action in a short time span whereas some takes as long as two hours or even more. Thus, if the flow of dose is calculated improperly, there is a substantial chance of overdosing. If the medication is taken too quickly, there may occur some harmful side effects. Therapeutic drugs must always be dosed during administration at steady and/or predefined flow rates.
There is a flow sensor, which is a part of the system. The sensor connects to a computing unit, which is programmed to achieve in time drip of chemotherapy drug in cancer patient’s bloodstream. The computing unit gets input about chemotherapy drug and its approximate time to drip inside patient’s body from the touch display attached with keypad facility. The computing unit and touch display get the power supply. There is an attached valve management actuator and sensor that receives the command from computing unit and sets the valve to control the flow of chemotherapy drug as instructed by the oncology specialists through the computing device. The entire system connected with the cloud server that stores the entire data and will be operated through wireless connection.
It improves cancer patient care by automating the chemotherapy drug drip flow monitoring, reduces manual labor on oncology healthcare professionals, and improves precision and reliability associated with chemotherapy drug fluid delivery. At design, data security and health compliance are kept at the top to ensure a highly safe transfer and storage of cancer patient information. Its scalability, with deployment across several oncology hospital rooms and locations, improves overall operational effectiveness in oncology healthcare settings.
Thus, this Auto Drip system is a big jump in care technology within oncology hospitals because it combines accuracy, automation, and real-time data analysis for supporting better patient outcomes and more effective oncology healthcare delivery.
PROBLEM ADDRESSED BY THE INVENTION
1. Conventional chemotherapy drip rate monitoring usually relies on the nursing staff to physically check the flow of chemotherapy drug, which is prone to human error in terms of omitted checks or mis-readings. This invention automates the monitoring process to ensure an accurate and trustworthy chemotherapy drug to drip.
2. This wastes a great deal of time for any nurse who might check the fluid levels, which takes that nurse away from other more important cancer patient care duties. This system frees oncology nursing staff time for more complex care duties.
3. If the detection of slow or fast fluid rate is not timely the there can arise some challenging and hazardous situations.
4. Such inconsistencies in chemotherapy fluid administration may be a function of manual monitored editions. This way, the system is guaranteeing consistency and precision in readings of drip flow rates with standardized monitoring practices.
5. Manual monitoring involves a lot of labor; it is inefficient, too, and increases the operating expenses only to lower productivity. In automating the process, the system reduces costs and improves operational efficiency.
US20/0390974 A1 Disclosed are methods and apparatuses for determining analyte concentrations in bodily fluids, which include a treatment dosing system to inject doses such as insulin or dextrose for glycemic control. The dose is based on the patient's sensitivity, analyte concentration, its average value, and rate of change. Delivery of the treatment drug can be halted if the analyte concentration indicates a need to stop.
RESEARCH GAP: Automatic chemotherapy drip flow monitoring system consists a touch display unit equipped with keypad for input facility about chemotherapy drug and drip duration. Further a programmed computing unit fetch this data to command the valve management actuator and sensor to set the drip flow duration. The entire system is connected to the cloud server through Wi-Fi facility. The cloud server data can be assessed through mobile application or desktop system for further analytics.
EEP 2291207B1 207B1 The invention relates to a medical fluid circuit and a control method of a medical fluid circuit. It can be usefully applied in supplying a medical fluid, such as for example an infusion fluid or a dialysis fluid.
RESEARCH GAP: This invention uses a valve management actuator and sensor that gets the command from computing unit to set the flow according to the instructions. There is a touch display equipped with keypad facility to input the data about chemotherapy drug and rate of flow. This command is fetched by the computing device for further process.
US 10549031B2 The invention administer that there is a need for dosing therapeutic agents at constant and/or predetermined flow rate and developed a infusion system for the controlled delivery of therapeutic agents.
RESEARCH GAP: This invention uses a valve management actuator and sensor that gets the command from computing unit to set the flow according to the instructions. There is a touch display equipped with keypad facility to input the data about chemotherapy drug and rate of flow. This command is fetched by the computing device for further process.
None of the prior art indicate above either alone or in combination with one another disclose what the present invention has disclosed. This invention relates to Drip Monitoring System for Cancer Patients During Chemotherapy.
SUMMARY OF THE INVENTION
This summary is provided to introduce a selection of concepts, in a simplified format, that are further described in the detailed description of the invention.
This summary is neither intended to identify key or essential inventive concepts of the invention and nor is it intended for determining the scope of the invention.
To further clarify advantages and features of the present invention, a more particular description of the invention will be rendered by reference to specific embodiments thereof, which is illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. The invention will be described and explained with additional specificity and detail with the accompanying drawings.
It utilizes a computing unit programmed with the information of chemotherapy drug and it drip timing for cancer patient. It gets input from the touch display (20) and the power supply from a power unit and a wireless connectivity to transmit the information to the valve management actuator that sets the flow of the drug accordingly. It sends the data to the cloud server further connected to the mobile or desktop application.
It utilizes a touch display equipped with keypad. Oncologists can insert the name of chemotherapy drug and timing for dip into the patient’s body. This command is received by the programmed computing unit that further instruct valve management actuator and sensor to set the flow rate of the chemotherapy.
It utilizes flow sensor placed near the chemotherapy drip chamber to accurately measure the flow of the chemotherapy drug.
BRIEF DESCRIPTION OF THE DRAWINGS
The illustrated embodiments of the subject matter will be understood by reference to the drawings, wherein like parts are designated by like numerals throughout. The following description is intended only by way of example, and simply illustrates certain selected embodiments of devices, systems, and methods that are consistent with the subject matter as claimed herein, wherein:
FIGURE 1: SYSTEM ARCHITECTURE
The figures depict embodiments of the present subject matter for the purposes of illustration only. A person skilled in the art will easily recognize from the following description that alternative embodiments of the structures and methods illustrated herein may be employed without departing from the principles of the disclosure described herein.
DETAILED DESCRIPTION OF THE INVENTION
The detailed description of various exemplary embodiments of the disclosure is described herein with reference to the accompanying drawings. It should be noted that the embodiments are described herein in such details as to clearly communicate the disclosure. However, the amount of details provided herein is not intended to limit the anticipated variations of embodiments; on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the scope of the present disclosure as defined by the appended claims.
It is also to be understood that various arrangements may be devised that, although not explicitly described or shown herein, embody the principles of the present disclosure. Moreover, all statements herein reciting principles, aspects, and embodiments of the present disclosure, as well as specific examples, are intended to encompass equivalents thereof.
The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of example embodiments. As used herein, the singular forms “a",” “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises,” “comprising,” “includes” and/or “including,” when used herein, specify the presence of stated features, integers, steps, operations, elements and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components and/or groups thereof.
It should also be noted that in some alternative implementations, the functions/acts noted may occur out of the order noted in the figures. For example, two figures shown in succession may, in fact, be executed concurrently or may sometimes be executed in the reverse order, depending upon the functionality/acts involved.
In addition, the descriptions of "first", "second", “third”, and the like in the present invention are used for the purpose of description only, and are not to be construed as indicating or implying their relative importance or implicitly indicating the number of technical features indicated. Thus, features defining "first" and "second" may include at least one of the features, either explicitly or implicitly.
Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which example embodiments belong. It will be further understood that terms, e.g., those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
It utilizes a computing unit programmed with the information of chemotherapy drug and it drip timing for cancer patient. It gets input from the touch display (20) and the power supply from a power unit and a wireless connectivity to transmit the information to the valve management actuator that sets the flow of the drug accordingly. It sends the data to the cloud server further connected to the mobile or desktop application.
It utilizes a touch display equipped with keypad. Oncologists can insert the name of chemotherapy drug and timing for dip into the patient’s body. This command is received by the programmed computing unit that further instruct valve management actuator and sensor to set the flow rate of the chemotherapy.
It utilizes flow sensor placed near the chemotherapy drip chamber to accurately measure the flow of the chemotherapy drug.
The invention is an advanced automated chemotherapy drug administration system that ensures accurate and efficient drug delivery for cancer patients. It utilizes a computing unit (10) programmed with chemotherapy drug details and its corresponding drip timing. The system receives inputs via a touch display (20) and draws power from a power supply unit. Wireless connectivity enables data transmission to the valve management actuator and sensor (30), which regulates the drug’s flow rate based on the prescribed dosage and timing.
Additionally, the system is linked to a cloud server, which synchronizes data with a mobile or desktop application. This allows oncologists and medical staff to remotely monitor and adjust chemotherapy administration parameters. The computing unit processes the received commands and communicates with the flow sensor placed near the drip chamber to ensure precise drug flow monitoring.
Components of the System
1. Computing Unit (10)
Central processing unit programmed with chemotherapy drug information and dosage schedules.
Receives input from the touch display and processes drug flow commands.
Communicates with the valve management actuator and sensor to regulate flow rates.
2. Touch Display & Keypad (20)
Equipped with a user-friendly interface for oncologists to input chemotherapy drug names and timing details.
Sends commands to the computing unit for processing.
3. Valve Management Actuator and Sensor (30)
Receives instructions from the computing unit to regulate drug flow.
Ensures precise control over drug administration, reducing dosing errors.
4. Flow Sensor
Placed near the chemotherapy drip chamber to accurately measure drug flow rate.
Provides real-time feedback to the computing unit for continuous monitoring and adjustments.
5. Power Supply Unit
Ensures an uninterrupted power source for the system's operation.
6. Cloud Server and Wireless Connectivity
Connects the system to a cloud server for remote monitoring and data logging.
Enables oncologists to track treatment progress via a mobile or desktop application.
ADVANTAGES OF THE INVENTION
• It ensures accurate and timely administration of medications and fluids, reducing the risk of under- or over-dosing.
• It minimizes human errors in manual monitoring of drip levels, enhancing patient care quality.
• It gives information on drip monitoring, allows immediate intervention to take place, and avoids treatment disruptions.
• It enhances the workflow efficiency of the nursing staff by automating routine monitoring tasks and alerting them only in case of a need.
, Claims:1. A system for automated chemotherapy drug administration, comprising:
A computing unit (10) programmed with chemotherapy drug details and corresponding drip timing, configured to process input commands and control drug flow;
A touch display and keypad (20) for receiving user input, allowing oncologists to enter drug name and infusion parameters;
A power supply unit for providing continuous operational power to the system;
A valve management actuator and sensor (30) configured to regulate and control the flow of chemotherapy drugs into a patient’s body based on commands received from the computing unit;
A flow sensor positioned near the drip chamber to monitor and ensure accurate flow of chemotherapy drugs;
A wireless communication module enabling real-time data transmission between the computing unit and a cloud server for remote monitoring and control via a mobile or desktop application.
2. The system as claimed in claim 1, wherein the sensors utilize flow sensing technology to calculate the flow rate of chemotherapy drug.
3. The system as claimed in claim 1 wherein the system communicates with said sensors via wireless communication medium, Wi-Fi.
4. The system as claimed in claim 1 wherein the system further includes a user interface available to healthcare providers via mobile devices or computers.